|
|
|
|
A New Treatment Option for Patients With Previously Treated Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Learning Objectives:
- Provide an overview of HNSCC and review the role of the immune system in cancer
- Review clinical data on KEYTRUDA for the treatment of patients with recurrent or metastatic HNSCC
- Identify patients with recurrent or metastatic HNSCC appropriate for treatment with KEYTRUDA
Live viewing followed by peer case discussion moderated by a speaker is available at the following locations. Please contact your Merck representative directly or send an email to GEEM_Operations@merck.com to participate live at any of these locations:
August 24, 2016 6:30 pm EST- Two Chefs Restaurant, Miami, FL
- Fogo de Chão, Atlanta, GA
- Big Rock Chop House, Troy, MI
- Angus Barn, Raleigh, NC
- Riverpark Restaurant, New York, NY
August 25, 2016 6:30 pm CST- Dharma Blue, Pensacola, FL
- Mastro's Steakhouse, Chicago, IL
- Cafe Trio Restaurant, Kansas City, MO
- Sidney Street Cafe, St. Louis, MO
- Truluck's, Dallas, TX
- Pappadeaux Seafood Kitchen, Houston, TX
August 30, 2016 6:30 pm PST- Mastro's City Hall, Scottsdale, AZ
- Lawry's The Prime Rib, Beverly Hills, CA
- Fogo de Chão, San Francisco, CA
- Roy's Restaurant, Las Vegas, NV
- El Gaucho, Seattle, WA
- Shanahan’s, Denver, CO
|
|
|